Search results for "mutation."

showing 10 items of 2808 documents

Naro. Architetture nei luoghi del dissesto

2013

The reserch has been carried out in the degree laboratory in architectural design by professor G.F. Tuzzolino at the Faculty of Architecture of Palermo. It intends to study the relationship between place and artifice in the historical, landscape, and architectural point of view Naro is a very important city that today appears seriously compromised by incoherent mutations and where you can see the serious problems of hidrogeological disorder.

Settore ICAR/14 - Composizione Architettonica E UrbanaArchitecture Place Mutations
researchProduct

CubeHarmonic: A new musical instrument based on Rubik{'}s cube with embedded motion sensor

2019

A contemporary challenge involves scientific education and the connection between new technologies and the heritage of the past. CubeHarmonic (CH) joins novelty and tradition, creativity and edu- cation, science and art. It takes shape as a novel musical instrument where magnetic 3D motion tracking technology meets musical per- formance and composition. CH is a Rubik’s cube with a note on each facet, and a chord or chord sequence on each face. The posi- tion of each facet is detected through magnetic 3D motion tracking. While scrambling the cube, the performer gets new chords and new chord sequences. CH can be used to compose, improvise,1 and teach music and mathematics (group theory, permu…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniSettore INF/01 - InformaticaComputer scienceSound computingPermutationsMusical instrumentMusicalMusic and mathematicsTonnetzinterfacescombinatoricComputer graphics (images)Chord (music)ChordsTonnetzChords; Magnetic 3D motion tracking; Permutations; Tonnetz;Magnetic 3D motion tracking
researchProduct

Hypercube + Rubik’s Cube + Music = HyperCubeHarmonic

2022

Musical chords and chord relations can be described through mathematics. Abstract permutations can be visualized through the Rubik’s cube, born as a pedagogical device [7,21]. Permutations of notes can also be heard through the CubeHarmonic, a novel musical instru- ment. Here, we summarize the basic ideas and the state of the art of the physical implementation of CubeHarmonic, discussing its conceptual lift- ing up to the fourth dimension, with the HyperCubeHarmonic (HCH). We present the basics of the hypercube theory and of the 4-dimensional Rubik’s cube, investigating its potential for musical applications. To gain intuition about HCH complexity, we present two practical implementa- tions…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniSettore MAT/02 - AlgebraSettore INF/01 - InformaticaPermutationChordRubik’s cubeHypergeometryMobileTonnetz
researchProduct

I vincoli della trasformazione: riflessioni sulla metamorfosi tra letteratura, filosofia e biologia

2019

Per sopravvivere gli esseri viventi sono costretto a modificarsi di continuo, adattandosi all’ambiente e al variare delle circostanze. In questa costante alterazione formale come si conciliano identità e mutamento? Come può l’individuo preservarsi dal totale dissolvimento in qualcos’altro? Questi sono solo alcuni dei quesiti che nei secoli hanno spinto studiosi di Morfologia, Estetica e Biologia a indagare le trasformazioni organiche. Nella presente trattazione cercheremo di chiarire le somiglianze e le differenze fra alcuni concetti chiave del vocabolario della metamorfosi (trasformazione, permutazione, vincolo, libertà di cambiamento, modularità organica) adottando un approccio multidisci…

Settore M-FIL/04 - Esteticametamorphosis transformation permutation constraints modularity
researchProduct

Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma

2002

The p16INK4a gene, localized within chromosome 9p21, has been identified as a cyclin-dependent kinase inhibitor and may negatively regulate the cell cycle acting as a tumor suppressor. Genetic alterations involving the 9p21 region are common in human cancers. A consecutive series of 64 untreated patients (median of follow up 53 months) undergoing surgical resection for locally advanced laryngeal squamous-cell carcinomas (LSCCs) has been studied prospectively. Our purpose was to investigate p16 alterations (9p21 allelic loss, hypermethylation and point mutations) and their possible association with clinico-pathological data and flow cytometric variables (DNA-ploidy and S-phase fraction (SPF)…

Settore MED/06 - Oncologia MedicaPhysiologyClinical BiochemistryLoss of HeterozygosityBiologyBioinformaticsS PhaseLoss of heterozygosityp16INK4aHumansPoint MutationProspective StudiesLaryngeal NeoplasmsGeneProportional Hazards ModelsUnivariate analysisPloidiesBase SequenceProportional hazards modelGenes p16Point mutationSingle-strand conformation polymorphismDNA NeoplasmCell BiologyDNA MethylationCell cyclePrognosisMultivariate AnalysisDNA methylationCarcinoma Squamous CellCancer researchChromosomes Human Pair 9Journal of Cellular Physiology
researchProduct

Identification and Characterization of BRCA1 and BRCA2 Founder Mutations

2012

A large number of cancer predisposing BRCA1/BRCA2 mutations have been reported, with a wide variety among populations. In some restricted groups, specific germline mutations in these tumor suppressor genes have been found with high predominance, due to a founder effect. We focused our review on the Italian founder mutations. The first Italian BRCA1 founder mutation, 5083del19, was found in Calabria: the presence of common allele in all carriers of this mutation (also in families with Calabrian origin living in other parts of Italy) confirmed its founder effect. The same BRCA1 mutation was identified in the Sicilian population, but only the haplotype analysis can reveal the common ancestor o…

Settore MED/06 - Oncologia Medicabusiness.industryObstetrics and GynecologyMedicineIdentification (biology)Computational biologyBRCA1; BRCA2; Founder mutationBRCA1Founder mutationbusinessBRCA2Current Women's Health Reviews
researchProduct

Analysis of early strains of the norovirus pandemic variant GII.4 Sydney 2012 identifies mutations in adaptive sites of the capsid protein.

2014

AbstractGlobal surveillance for norovirus identified in 2012 the emergence of a novel pandemic GII.4 variant, termed Sydney 2012. In Italy, the novel pandemic variant was identified as early as November 2011 but became predominant only in the winter season 2012–2013. Upon sequencing and comparison with strains of global origin, the early Sydney 2012 strains were found to differ from those spreading in 2012–2013 in the capsid (ORF2) putative epitopes B, C and D, segregating into a distinct phylogenetic clade. At least three residues (333, 340 and 393, in epitopes B, C and D, respectively) of the VP1 varied among Sydney 2012 strains of different clades. These findings suggest that the spread …

Settore MED/07 - Microbiologia E Microbiologia ClinicaEvolutionMolecular Sequence DataCapsid protein VP1 epitopes Evolution GII.4 Italy Norovirus Sydney 2012 variantBiologymedicine.disease_causeEpitopeSydney 2012 variantVirologyPandemicmedicineHumansAmino Acid SequenceCladePandemicsPhylogenyPhylogenetic treeNorovirusCapsid protein VP1 epitopesVirologyGastroenteritisCapsidItalyMutationNorovirusCapsid ProteinsSeasonsWinter seasonGII.4Virology
researchProduct

Identification of a novel ANGPTL3 mutation splicing associeted to severe hypobetalipoproteinemia

2012

Introduction. Primary hypobetalipoproteinemia (pHBL) is a monogenic heterogeneous condition inherited as a dominant or recessive trait characterized by total cholesterol (TC) and/or LDL cholesterol (LDL-C) and/or apolipoprotein B (APOB) levels below the 5th percentile of the reference population. Heterozygous APOB gene mutations are responsible for the majority of the dominant pHBL causing the familial hypobetalipoproteinemia (FHBL). Loss-of-function mutations in the PCSK9 gene also cause FHBL. Familial combined hypolipidemia is a recently discovered dyslipidemic phenotype characterized by low levels of TC, triglycerides (TG), LDL-C, and high-density lipoprotein cholesterol (HDL-C). The gen…

Settore MED/09 - Medicina InternaANGPTL3mutationHypobetalipoproteinemia
researchProduct

Lipid and apoprotein composition of HDL in partial or complete CETP deficiency

2012

Hyperalphalipoproteinemia, as observed in patients who are either homozygous or heterozygous for cholesteryl ester transfer protein (CETP) deficiency, has been shown to be associated with striking changes in apolipoprotein size distribution, namely, of high-density lipoprotein (HDL) and HDL-like particles. We compared the effect of varying degrees of CETP activity on the HDL apolipoprotein profile in Caucasian CETP-deficient subjects and following pharmacological decrease in CETP activity, using Size Exclusion Chromatography followed by Reverse Phase Protein Array (SEC RPA). The main HDL-associated apolipoproteins (Apo), i.e. ApoA-I, ApoA-II, ApoC-I, and ApoC-III, co-eluted with the HDL pea…

Settore MED/09 - Medicina InternaApolipoprotein BCholesterol Ester Transfer Proteinmedicine.disease_causereverse phase protein arraychemistry.chemical_compoundExonMutationbiologyHomozygotescavenger receptor class B1size exclusion chromatographyLipidCholesteryl ester transfer proteinLipidstorcetrapibApolipoproteinBiochemistryELISAlipids (amino acids peptides and proteins)hyperalphalipoproteinemiaCardiology and Cardiovascular MedicineLipoproteins HDLHumandalcetrapibmedicine.medical_specialtyHeterozygoteDalcetrapibHypercholesterolemiaapolipoproteinhigh-density lipoproteinInternal medicineCholesterylester transfer proteinmedicineAnimalsHumansCholesteryl ester transfer protein; dalcetrapib; high-density lipoprotein; reverse phase protein array; scavenger receptor class B1; size exclusion chromatography; torcetrapib; apolipoprotein; hyperalphalipoproteinemia; ELISAPharmacologybusiness.industryAnimalPoint mutationCholesterol HDLTorcetrapibnutritional and metabolic diseasesLipid MetabolismCholesterol Ester Transfer Proteinscarbohydrates (lipids)Disease Models AnimalEndocrinologyApolipoproteinschemistrybiology.proteinbusinessLipoprotein
researchProduct

eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency.

2014

Mutations in the CETP gene resulting in defective CETP activity have been shown to cause remarkable elevations of plasma HDL-C levels, with the accumulation in plasma of large, buoyant HDL particles enriched in apolipoprotein E. Genetic CETP deficiency thus represents a unique tool to evaluate how structural alterations of HDL impact on HDL atheroprotective functions. Aim of the present study was to assess the ability of HDL obtained from CETP-deficient subjects to protect endothelial cells from the development of endothelial dysfunction. HDL isolated from one homozygous and seven heterozygous carriers of CETP null mutations were evaluated for their ability to down-regulate cytokine-induced…

Settore MED/09 - Medicina InternaCHOLESTEROL EFFLUXApolipoprotein BEpidemiologylcsh:MedicineANTIINFLAMMATORY PROPERTIESmedicine.disease_causeBiochemistryVascular Medicinechemistry.chemical_compoundHigh-density lipoproteinEnosMedicine and Health SciencesEndothelial dysfunctionlcsh:ScienceMutationMultidisciplinarybiologyHomozygoteCETP; eNOS; HDL;NeurochemistryLipidsGenetic EpidemiologyeNOSlipids (amino acids peptides and proteins)AnatomyNeurochemicalsLipoproteins HDLResearch Articlemedicine.medical_specialtyDrug Research and DevelopmentHDLNitric Oxide Synthase Type IIILipoproteinsENDOTHELIAL FUNCTIONINHIBITIONCardiologyDown-RegulationVascular Cell Adhesion Molecule-1Nitric OxideCELL-ADHESION MOLECULE-1Lipid Metabolism Inborn ErrorsESTER TRANSFER PROTEINInternal medicineCETPCholesterylester transfer proteinHuman Umbilical Vein Endothelial CellsmedicineHumansNITRIC-OXIDE SYNTHASEInflammationClinical GeneticsPharmacologyCholesterollcsh:RTorcetrapibEndothelial CellsBiology and Life SciencesProteinsnutritional and metabolic diseasesLipid MetabolismAtherosclerosismedicine.diseasebiology.organism_classificationCholesterol Ester Transfer Proteinscarbohydrates (lipids)MetabolismEndocrinologychemistryOther Clinical MedicineMutationImmunologyCardiovascular Anatomybiology.proteinlcsh:QTORCETRAPIBClinical MedicineHIGH-DENSITY-LIPOPROTEINSCAVENGER RECEPTOR BI
researchProduct